vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-1127Research ArticleВ ПОМОЩЬ ВРАЧУA DOCTOR’S AIDВАКЦИНАЦИЯ ПРОТИВ ВЕТРЯНОЙ ОСПЫ. ОТВЕЧАЕМ НА ВОПРОСЫ ПЕДИАТРОВTHE VACCINATION AGAINST VARICELLA. THE ANSWERS TO THE PEDIATRISTS QUESTIONSТаточенкоВ.К.TatochenkoV.К.Научный центр здоровья детей РАМН, МоскваРоссияScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowRussian Federation20092309201583Вопросы современной педиатрии114119Copyright © Таточенко В., 20092009Таточенко В.Tatochenko V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1127ReferencesVaris T., Vesikari T. Efficacy of a high-titre live attenuated varicella vaccine in healthy young children. J. Infect. Dis. 1996; 174 (Suppl. 3): 330−334.Varis T., Vesikari T. Efficacy of a high-titre live attenuated varicella vaccine in healthy young children. J. Infect. Dis. 1996; 174 (Suppl. 3): 330−334.Vesikari T., Baer M., Varis T., et al. Efficacy of varicella vaccine is dependent on the virus titre. 1st World Congress of Pediatric Infectious Diseases. Acupulco, Mexico. 4−7 December 1996. Abstract: 1996.Vesikari T., Baer M., Varis T., et al. Efficacy of varicella vaccine is dependent on the virus titre. 1st World Congress of Pediatric Infectious Diseases. Acupulco, Mexico. 4−7 December 1996. Abstract: 1996.Miron D., Lavi I., Kitov R. et al. Vaccine eff ectiveness and severity of varicella among previously vaccinated children during outbreaks in day care centers with low vaccination coverage. Pediatr. Infect. Dis. J. 2005; 24 (3): 233–236.Miron D., Lavi I., Kitov R. et al. Vaccine eff ectiveness and severity of varicella among previously vaccinated children during outbreaks in day care centers with low vaccination coverage. Pediatr. Infect. Dis. J. 2005; 24 (3): 233–236.Kreth H.W., Lee B.W., Kosuwon P. et al. Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix). Biodrugs. 2008; 22 (6): 387–402.Kreth H.W., Lee B.W., Kosuwon P. et al. Sixteen years of global experience with the first refrigerator-stable varicella vaccine (Varilrix). Biodrugs. 2008; 22 (6): 387–402.Meurice F., De Bouver L., Vandevoorde D. et al. Immunogenicity and safety of a live attenuated varicella vaccine (Oka/SB Bio) in healthy children. J. Infect. Dis. 1996; 174 (Suppl. 3): 324−329.Meurice F., De Bouver L., Vandevoorde D. et al. Immunogenicity and safety of a live attenuated varicella vaccine (Oka/SB Bio) in healthy children. J. Infect. Dis. 1996; 174 (Suppl. 3): 324−329.Burgess M.A., Cossart Y.E., Wilkins T.D. et al. Varicella vaccination of health care workers. Vaccine. 1999; 17 (7-8): 765−769.Burgess M.A., Cossart Y.E., Wilkins T.D. et al. Varicella vaccination of health care workers. Vaccine. 1999; 17 (7-8): 765−769.Ragozzino M.W., Melton L.J., Kurland L.T. et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982; 61 (5): 310–316.Ragozzino M.W., Melton L.J., Kurland L.T. et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982; 61 (5): 310–316.Thomas S.L., Hall A.J. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect. Dis. 2004; 4 (1): 26–33.Thomas S.L., Hall A.J. What does epidemiology tell us about risk factors for herpes zoster? Lancet Infect. Dis. 2004; 4 (1): 26–33.Richards P. Shingles in one family practice. Arch. Fam. Med. 1996; 5 (1): 42–46.Richards P. Shingles in one family practice. Arch. Fam. Med. 1996; 5 (1): 42–46.Schmader K., George L.K., Burchett B.M. et al. Racial differences in the occurrence of herpes zoster. J. Infect. Dis. 1995; 171 (3): 701–704.Schmader K., George L.K., Burchett B.M. et al. Racial differences in the occurrence of herpes zoster. J. Infect. Dis. 1995; 171 (3): 701–704.Donahue J.G., Choo P.W., Manson J.E., et al. The incidence of herpes zoster. Arch. Intern. Med. 1995; 155 (15): 1605–1609.Donahue J.G., Choo P.W., Manson J.E., et al. The incidence of herpes zoster. Arch. Intern. Med. 1995; 155 (15): 1605–1609.Mor M., Harel L., Kahan E., et al. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting – a pilot study. Vaccine. 2004; 23 (3): 325–328.Mor M., Harel L., Kahan E., et al. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting – a pilot study. Vaccine. 2004; 23 (3): 325–328.Bekker V., Westerlaken G.H., Scherpbier H. et al. Varicella vaccination in HIV-1-infected children after immune reconstitution. AIDS. 2006; 20 (18): 2321-2329.Bekker V., Westerlaken G.H., Scherpbier H. et al. Varicella vaccination in HIV-1-infected children after immune reconstitution. AIDS. 2006; 20 (18): 2321-2329.
The authors declare that there are no conflicts of interest present.